Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Treratwolfram

In this page

Clinical Trial

2017-001215-37 Completed
Treratwolfram

A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome

Interventional
Interventional

Disease

Disease type

Paediatric clinical trials

Wolfram

Orphan drug recognition

No

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

15/10/2020

Closing date

31/08/2021

Inclusion criteria :

More

Exclusion criteria :

More

Funding

public

Members involved

Others investigators

Pr Isabelle MEUNIER

Representative

France

Retinal Rare Eye Diseases (WG1)
See more

ERN EYE member investigating site

HCP : Principal investigators

Reference Center Rare Diseases ‘Genetic Sensory Diseases’, MAOLYA, Montpellier, France

Adress

Hôpital Gui de ChauliacService Ophtalmologie80, avenue Augustin Fliche 1er étage, bureau 1414

34 295 Montpellier Cedex 5

France

HCP : Others investigators

OPHTARA – Hôpital Européen Georges Pompidou, Paris, France

Adress

Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres

75 015 Paris

France